What is the published evidence on the accuracy, turnaround time and cost/cost-effectiveness of tests to identify carbapenemase producing Enterobacteriaceae (CPE) in hospital screening samples obtained from patients identified as at risk of CPE colonisation during clinical risk assessment?
Healthcare Improvement Scotland.
"In response to an inquiry from Health Protection Scotland."--page 1.
Includes bibliographical references (pages 19-21).
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 9 October 2019)
Communicable diseases
Enterobacteriaceae
Diagnosis, Laboratory